Hoehcst Pakistan Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, HPL's sales rose 3% to Rs 9.0bn, from Rs 8.7bn, and profit after tax rose 87% to Rs 1.5bn, from Rs 790.0mn (compared with Apr–Jun 2025).
Earnings per share were Rs 152.94, against Rs 81.94 a year earlier. The company reported a dividend of Rs 80.00 per share for the quarter.
At Rs 3970.10, HPL trades at 10.4 times earnings, with a dividend yield of 6.0%.
- P/E ratio
- 10.4
- Dividend yield
- 6.0%
- Dividend payout
- 52%
- of earnings
- Return on equity
- 44%
- Net margin
- 12.0%
- trailing twelve months
- Debt to equity
- 0.06
HPL quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 9.0bn | Rs 1.5bn | 16.4% | Rs 152.94 | Rs 80.00 |
| Jan–Mar 2026 | Rs 7.7bn | Rs 721.0mn | 9.4% | Rs 74.71 | — |
| Oct–Dec 2025 | Rs 6.4bn | Rs 690.0mn | 10.8% | Rs 71.54 | Rs 190.00 |
| Jul–Sep 2025 | Rs 8.3bn | Rs 876.0mn | 10.6% | Rs 90.79 | — |
| Apr–Jun 2025 | Rs 8.7bn | Rs 790.0mn | 9.1% | Rs 81.94 | Rs 50.00 |
| Jan–Mar 2025 | Rs 7.6bn | Rs 554.0mn | 7.3% | Rs 57.40 | — |
| Oct–Dec 2024 | Rs 6.2bn | Rs 654.0mn | 10.5% | Rs 67.63 | Rs 110.00 |
| Jul–Sep 2024 | Rs 7.2bn | Rs 379.0mn | 5.3% | Rs 39.29 | — |
HPL annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Dec 2025 | Rs 30.9bn | Rs 2.9bn | Rs 301.67 | Rs 240.00 |
| Year to Dec 2024 | Rs 26.7bn | Rs 1.9bn | Rs 192.56 | Rs 135.00 |
| Year to Dec 2023 | Rs 21.4bn | Rs 361.0mn | Rs 37.41 | Rs 30.00 |
| Year to Dec 2022 | Rs 18.6bn | Rs 167.0mn | Rs 17.29 | — |
| Year to Dec 2021 | Rs 15.9bn | Rs 906.0mn | Rs 93.93 | Rs 30.00 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 15.5bn
- Shareholders' equity
- Rs 8.6bn
- Cash & bank
- Rs 229.0mn
- Total debt
- Rs 472.0mn
- Current ratio
- 1.75
- 3-month high
- Rs 4150.04
- 3-month low
- Rs 3861.54
- 1-month change
- -1.3%
- 3-month change
- -1.4%
Read more about HPL
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
HPL: common questions
What is HPL's share price?
Hoehcst Pakistan Ltd (HPL) last closed at Rs 3970.10 on the Pakistan Stock Exchange.
Does HPL pay a dividend?
Yes. Hoehcst Pakistan Ltd paid Rs 240.00 per share for the year to Dec 2025, and the stock's dividend yield is 6.0%.
What were HPL's latest results?
In the Apr–Jun 2026 quarter, HPL's sales rose 3% to Rs 9.0bn, from Rs 8.7bn, and profit after tax rose 87% to Rs 1.5bn, from Rs 790.0mn (compared with Apr–Jun 2025).
What is HPL's P/E ratio?
At Rs 3970.10, HPL trades at 10.4 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.